8-K: FitLife Brands Reports Strong Q2 2024 Results Driven by Online Sales and Strategic Acquisitions

FitLife Brands announced a 15% increase in total revenue and a 29% increase in adjusted EBITDA for the second quarter of 2024, driven by strong online sales and the performance of acquired brands.

Summary

• FitLife Brands reported a 15% increase in total revenue, reaching $16.9 million in the second quarter of 2024, compared to $14.8 million in the same period last year.
• Online sales accounted for 66% of total revenue, totaling $11.2 million, a 13% increase year-over-year.
• Wholesale revenue increased by 18% to $5.7 million, with recent acquisitions contributing $1.5 million, while legacy FitLife wholesale revenue declined by 10%.
• Gross margin improved to 44.8% from 40.4% in the second quarter of 2023.
• Net income rose to $2.6 million, compared to $2.0 million in the same quarter of the previous year.
• Basic earnings per share were $0.57, and diluted earnings per share were $0.53, up from $0.44 and $0.40, respectively, in the second quarter of 2023.
• Adjusted EBITDA increased by 29% to $3.8 million.
• The company's net debt stands at $11.7 million, with $15.4 million in term loans and $3.7 million in cash.
• The company's revolving line of credit of $3.5 million remains undrawn.
• Legacy FitLife revenue declined by 5%, with a 10% decrease in wholesale revenue partially offset by a 7% increase in online revenue.
• MRC revenue declined by 2%, but gross profit increased by 21% and contribution increased by 61% due to strategic optimization.
• MusclePharm revenue increased 27% sequentially from the first quarter of 2024, with wholesale revenue increasing 24% and online revenue increasing 31%.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, strategic acquisitions, and improved profitability. The company's focus on online sales and optimization of acquired brands is encouraging. However, there are some challenges in the wholesale channel and potential risks associated with future growth.

Positives

• The company experienced a significant increase in total revenue, driven by strong online sales.
• Gross margins improved substantially, indicating better profitability.
• Net income and earnings per share saw considerable growth compared to the same period last year.
• Adjusted EBITDA increased significantly, reflecting improved operational performance.
• The company's net debt is manageable, with a strong cash position.
• The MusclePharm brand showed strong sequential growth in revenue.
• MRC's profitability improved significantly due to strategic optimization efforts.
• The company's online sales continue to grow, offsetting some of the decline in wholesale revenue.

Negatives

• Legacy FitLife experienced a 5% decline in revenue, primarily due to a 10% decrease in wholesale revenue.
• MRC's overall revenue declined by 2% year-over-year.
• The company's wholesale revenue continues to be challenged by declining customer counts in brick-and-mortar stores.
• The skin care brands within MRC experienced a 37% decline in revenue, although this was due to a strategic decision to exit unprofitable markets.

Risks

• The company faces challenges in the wholesale channel due to declining foot traffic at brick-and-mortar retail partners.
• The company's future performance is subject to risks and uncertainties, including the ability to continue to grow revenue and achieve positive cash flow.
• The company's reliance on online sales makes it vulnerable to changes in online consumer behavior and competition.
• The company's acquisitions may not perform as expected, impacting overall financial results.

Future Outlook

The company intends to continue investing in advertising and promotion to drive growth, particularly for the MusclePharm brand. They are also evaluating M&A opportunities while building cash reserves. The company will continue to provide detailed performance metrics for acquired brands for up to two years post-acquisition.

Management Comments

• Dayton Judd, the company's Chairman and CEO, stated that the company saw many bright spots in the business during the second quarter of 2024.
• He highlighted the growth of the Dr. Tobias brand within MRC, despite reduced advertising spend.
• He noted that while MRC's skin care brands' revenue declined, they are now substantially more profitable.
• He mentioned that the transition of wholesale revenue to online channels is helping maintain profitability for legacy FitLife brands.
• He expressed encouragement with the sequential growth of MusclePharm and plans to invest in its growth.
• He stated that the company's balance sheet is strong, with net debt representing approximately 0.9x adjusted EBITDA.
• He mentioned that the company is building cash as it continues to evaluate M&A opportunities.

Industry Context

The company's focus on online sales aligns with the broader trend of increasing e-commerce activity in the nutritional supplements and wellness products industry. The strategic acquisitions of MRC and MusclePharm are aimed at expanding the company's product portfolio and market reach, which is a common strategy in this competitive industry. The company's efforts to optimize the profitability of acquired brands by exiting unprofitable markets and raising prices are also in line with industry best practices.

Comparison to Industry Standards

• FitLife's 15% revenue growth in Q2 2024 is strong compared to the overall growth rate of the nutritional supplement industry, which is estimated to be in the single-digit range.
• The company's gross margin of 44.8% is competitive with other established players in the industry, such as Herbalife and Nu Skin, which typically report gross margins in the 40-50% range.
• The 29% increase in adjusted EBITDA is a significant improvement and suggests strong operational efficiency compared to peers.
• FitLife's focus on online sales is in line with the trend of direct-to-consumer sales, which is becoming increasingly important for companies in this sector. Companies like Amazon and iHerb are major competitors in this space.
• The company's strategic acquisitions are similar to moves made by other companies in the industry to expand their product offerings and market share. For example, Nestle acquired Atrium Innovations to expand its presence in the nutritional supplements market.
• FitLife's net debt to adjusted EBITDA ratio of 0.9x indicates a healthy balance sheet compared to some competitors that may have higher leverage.

Management Changes

Stakeholder Impact

• Shareholders will likely view the strong financial results and strategic initiatives positively.
• Employees may benefit from the company's growth and improved financial performance.
• Customers will continue to have access to the company's products through online and retail channels.
• Suppliers may see increased demand for their products as the company grows.
• Creditors may view the company's strong balance sheet and cash position favorably.

Next Steps

• The company will continue to invest in advertising and promotion to drive growth, particularly for the MusclePharm brand.
• The company will continue to evaluate M&A opportunities while building cash reserves.
• The company will hold an investor conference call on August 14, 2024, at 4:30 pm ET.

Key Dates

Keywords

nutritional supplements, wellness products, online sales, e-commerce, acquisitions, gross margin, EBITDA, net income, wholesale revenue, FitLife Brands, MusclePharm, Mimis Rock Corp, FTLF